4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide
C16H26ClNO3 — CID 143139714
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide
4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide (PubChem CID 143139714) has the molecular formula C16H26ClNO3 and a molecular weight of 315.84 g/mol. Its IUPAC name is 4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide.
Molecular Properties
| Compound Name | 4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide |
|---|---|
| PubChem CID | 143139714 |
| Molecular Formula | C16H26ClNO3 |
| Molecular Weight | 315.84 g/mol |
| Exact Mass | 315.16 |
| IUPAC Name | 4-chloro-N-(4-cyclohex-2-en-1-yl-2-methyl-1-oxobutan-2-yl)-2-methoxybutanamide |
| SMILES | COC(CCCl)C(=O)NC(C)(C=O)CCC1C=CCCC1 |
| InChI | InChI=1S/C16H26ClNO3/c1-16(12-19,10-8-13-6-4-3-5-7-13)18-15(20)14(21-2)9-11-17/h4,6,12-14H,3,5,7-11H2,1-2H3,(H,18,20) |
| InChIKey | HYSNWHBZFCRFCI-UHFFFAOYSA-N |
| XLogP | 2.84 |
| TPSA | 55.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 315.84 |
| LogP ≤ 5 | 2.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143139714 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.